Masimo (Masimo) Risk Assessment

View and export this data going back to 2007. Start your Free Trial

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Masimo is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison

For the Medical Devices subindustry, Masimo's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Masimo Risk Assessment Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Masimo's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Masimo's Risk Assessment falls into.

Masimo (NAS:MASI) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Masimo Risk Assessment Related Terms

Thank you for viewing the detailed overview of Masimo's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Masimo (Masimo) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Masimo Corp (NAS:MASI) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

MASI:Mexico 3M4:Germany 3M4:Germany

Address

52 Discovery, Irvine, CA, USA, 92618

Website

https://www.masimo.com

Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

Executives

Rolf A Classon	director	C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Politan Capital Management Gp Llc	other: Director by deputization	106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Partners Gp Llc	other: Director by deputization	106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Quentin Koffey	other: Director by deputization	POLITAN CAPITAL MANAGEMENT LP, 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Management Lp	other: Director by deputization	106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Michelle Brennan	director	1855 S. GRANT STREET, SAN MATEO CA 94402
Joe E Kiani	director, officer: CEO and Chairman of the Board	4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Paul Hataishi	officer: SVP, Chief Accounting Officer	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Blair Tripodi	officer: COO, Consumer Division	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Kevin P Duffy	officer: President, Consumer	1 VIPER WAY, VISTA CA 92081
Adam Mikkelson	director	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Tao Levy	officer: EVP BUS DEV	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Micah W Young	officer: EVP & Chief Financial Officer	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Thomas Samuel Mcclenahan	officer: EVP & GENERAL COUNSEL	40 PARKER, IRVINE CA 92618
Craig B Reynolds	director	1046 MIDDLEBROOK WAY, KENESAW GA 30144